Dementia Discovery Fund (DDF)

We are pleased to note that Rheostat, a biotech company focused on the discovery of novel treatments for neurodegeneration, cognition and rare diseases, has announced the closing of a $23 million Series A financing. Read the full press release here: theddfund.com/ddf-notes-rheo…

“The nice thing about a platform like this, and going against undruggable targets, is that you can go across all sorts of indications,” said CEO Solomon, who helped found Epizyme and served as its VP of discovery: fiercebiotech.com/biotech/ribome…

We're delighted to be working with the Dementia Discovery Fund (@TheDDFund) to launch D3A, an exciting accelerator programme that will move dementia science closer to the clinic. Find out more: ukdri.ac.uk/news-and-event…

Dementia Discovery Fund launches new research accelerator partnership with the @UKDRI at inaugural Annual Forum for Dementia. D3A will support important research projects with potential to create meaningful new medicines for dementia theddfund.com

Such an honour to speak at the @TheDDFund reception tonight - celebrating fundraising a staggering £250m in this unique collaboration to defeat #dementia

We're delighted to see that the NIH is funding a broad range of fresh ideas to help tackle Alzheimer's disease science.sciencemag.org/content/361/64… #Alzheimers @sciencemagazine

Since we launched in October 2015, the #DDF has made significant progress building an initial portfolio of 16 investments in drug discovery companies and projects predominantly in the UK and US #dementia. Find out more about us by visiting our website theddfund.com

Two NY Times articles today desperately highlight the need for @TheDDFund and its continued great work #_article03e38500-c189-46cf-8436-a931d003fa6a" target="_blank" rel="nofollow noopener">iht.newspaperdirect.com/epaper/iphone/…

The DDF aims to invest in #innovative approaches to bring disease-modifying drugs to the clinic for #dementia

The DDF is the world’s largest venture fund focused entirely on discovering novel treatments for #dementia including #alzheimers

The #DDF can provide guidance and hands-on support to help companies to develop innovative drugs for dementia patients. To find out more how we can help you, visit our website #dementiaresesearch #dementia #alzheimers theddfund.com

Great to see the US investing funds into #Alzheimers research

#DDF invests in truly novel, early-stage projects starting from target identification, and explore novel biological insights for translation into disease-modifying drugs for #dementia and #alzheimers

The #DDF can provide guidance and hands-on support to help companies to develop innovative drugs for dementia patients. To find out more how we can help you, visit our website #dementiaresesearch #dementia #alzheimers theddfund.com

“One of the key goals of the DDF is to bring diversity to the range of approaches that we’re going to use to attack dementia” Tetsu Maruyama, Chief Scientific Officer of the DDF.

The DDF does not only invest in existing companies, but also initiates projects to help create new drug discovery companies designed to explore new approaches to tackling #dementia. Find out more about how you can work with us theddfund.com

Did you know that dementia has higher health and social care costs (£11.9bn) than cancer (£5.0bn) and chronic heart disease (£2.5bn) combined. Click here for more revealing statistics: dementiastatistics.org

See how the brain works and how Alzheimer's affects it. Take our Brain Tour: bit.ly/2KDlrak.

The DDF has raised a total of $350 million to develop novel disease-modifying therapeutics for all forms of dementia. theddfund.com/video-25june20…

We would love to hear from scientists, researchers and companies developing novel therapies for Dementia, who need funding and help. You can get in touch with us through our website theddfund.com